K Na‐Bangchang

1.1k total citations
45 papers, 866 citations indexed

About

K Na‐Bangchang is a scholar working on Public Health, Environmental and Occupational Health, Pharmacology and Computational Theory and Mathematics. According to data from OpenAlex, K Na‐Bangchang has authored 45 papers receiving a total of 866 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Public Health, Environmental and Occupational Health, 15 papers in Pharmacology and 13 papers in Computational Theory and Mathematics. Recurrent topics in K Na‐Bangchang's work include Malaria Research and Control (42 papers), Computational Drug Discovery Methods (13 papers) and Drug-Induced Hepatotoxicity and Protection (12 papers). K Na‐Bangchang is often cited by papers focused on Malaria Research and Control (42 papers), Computational Drug Discovery Methods (13 papers) and Drug-Induced Hepatotoxicity and Protection (12 papers). K Na‐Bangchang collaborates with scholars based in Thailand, Vietnam and Austria. K Na‐Bangchang's co-authors include Juntra Karbwang, Kanungnit Congpuong, A Thanavibul, P. Molunto, J Karbwang, Peerapan Tan‐ariya, Le Ngoc Hung, Wilfred D. Stein, H. Ginsburg and Moshe Hoshen and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, American Journal of Tropical Medicine and Hygiene and British Journal of Clinical Pharmacology.

In The Last Decade

K Na‐Bangchang

45 papers receiving 835 citations

Peers

K Na‐Bangchang
A Thanavibul Thailand
J Karbwang Thailand
P. Molunto Thailand
Robert Mull Switzerland
Lars Rombo Sweden
P.A. Winstanley United Kingdom
Steven R. Meshnick United States
A Thanavibul Thailand
K Na‐Bangchang
Citations per year, relative to K Na‐Bangchang K Na‐Bangchang (= 1×) peers A Thanavibul

Countries citing papers authored by K Na‐Bangchang

Since Specialization
Citations

This map shows the geographic impact of K Na‐Bangchang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Na‐Bangchang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Na‐Bangchang more than expected).

Fields of papers citing papers by K Na‐Bangchang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Na‐Bangchang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Na‐Bangchang. The network helps show where K Na‐Bangchang may publish in the future.

Co-authorship network of co-authors of K Na‐Bangchang

This figure shows the co-authorship network connecting the top 25 collaborators of K Na‐Bangchang. A scholar is included among the top collaborators of K Na‐Bangchang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Na‐Bangchang. K Na‐Bangchang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hung, Le Ngoc, et al.. (2008). Absence of time-dependent artesunate pharmacokinetics in healthy subjects during 5-day oral administration. European Journal of Clinical Pharmacology. 64(10). 993–998. 24 indexed citations
2.
Na‐Bangchang, K, et al.. (2008). Development and validation of a liquid chromatography-mass spectrometry method for the simultaneous quantification of artesunate and dihydroartemisinin in human plasma.. Southeast Asian Journal of Tropical Medicine and Public Health. 39(6). 963–77. 9 indexed citations
3.
Sirivichayakul, Chukiat, Arunee Sabchareon, Krisana Pengsaa, et al.. (2007). Comparative study of the effectiveness and pharmacokinetics of two rectal artesunate/oral mefloquine combination regimens for the treatment of uncomplicated childhood falciparum malaria. Annals of Tropical Paediatrics. 27(1). 17–24. 11 indexed citations
4.
Na‐Bangchang, K, et al.. (2007). Clinical Efficacy of High Dose Monotherapy of Oral Dihydroartemisinin in Uncomplicated Falciparum Malaria in Viet Nam. Japanese Journal of Infectious Diseases. 60(4). 161–166. 2 indexed citations
5.
Pengsaa, Krisana, Chukiat Sirivichayakul, K Na‐Bangchang, et al.. (2005). Life-saving rectal artesunate for complicated malaria in children.. PubMed. 36(3). 597–601. 6 indexed citations
6.
Jirasiritham, S., V. Sumethkul, V. Mavichak, & K Na‐Bangchang. (2004). The pharmacokinetics of mycophenolate mofetil in Thai kidney transplant recipients. Transplantation Proceedings. 36(7). 2076–2078. 25 indexed citations
7.
Siripoon, Napaporn, et al.. (2002). Cryptic Plasmodium falciparum parasites in clinical P. vivax blood samples from Thailand. Transactions of the Royal Society of Tropical Medicine and Hygiene. 96(1). 70–71. 23 indexed citations
8.
Noedl, Harald, et al.. (2002). An in vitro system for assessing the sensitivity of Plasmodium vivax to chloroquine. Acta Tropica. 83(1). 49–61. 37 indexed citations
9.
Kikuchi, Mihoko, S Looareesuwan, Yupaporn Wattanagoon, et al.. (2001). Association of adhesion molecule PECAM-1/CD31 polymorphism with susceptibility to cerebral malaria in Thais. Parasitology International. 50(4). 235–239. 29 indexed citations
11.
Na‐Bangchang, K, et al.. (2000). Absence of significant pharmacokinetic and pharmacodynamic interactions between artemether and quinoline antimalarials. European Journal of Drug Metabolism and Pharmacokinetics. 25(3-4). 171–178. 5 indexed citations
12.
Tan‐ariya, Peerapan, et al.. (2000). In vitro sensitivity of Plasmodium falciparum and clinical response to lumefantrine (benflumetol) and artemether. British Journal of Clinical Pharmacology. 49(5). 437–444. 8 indexed citations
14.
Na‐Bangchang, K, et al.. (1999). Pharmacokinetics of benflumetol given as a fixed combination artemether-benflumetol (CGP 56697) in Thai patients with uncomplicated falciparum malaria.. PubMed. 19(2). 41–6. 5 indexed citations
15.
Karbwang, Juntra, et al.. (1998). Pharmacokinetics of Oral Artesunate in Thai Patients with Uncomplicated Falciparum Malaria. Clinical Drug Investigation. 15(1). 37–43. 21 indexed citations
16.
Karbwang, Juntra, et al.. (1997). Determination of artemether and its major metabolite, dihydroartemisinin, in plasma using high-performance liquid chromatography with electrochemical detection. Journal of Chromatography B Biomedical Sciences and Applications. 690(1-2). 259–265. 47 indexed citations
17.
Na‐Bangchang, K, et al.. (1997). Alternative method for determination of pyrimethamine in plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 689(2). 433–437. 6 indexed citations
18.
Na‐Bangchang, K, et al.. (1997). Compliance with a 2 day course of artemether‐mefloquine in an area of highly multi‐drug resistant Plasmodium falciparum malaria. British Journal of Clinical Pharmacology. 43(6). 639–642. 17 indexed citations
19.
Karbwang, Juntra, Kabkaew L. Sukontason, A Thanavibul, et al.. (1995). Comparison of artemether and quinine in the treatment of severe falciparum malaria in south-east Thailand. Transactions of the Royal Society of Tropical Medicine and Hygiene. 89(6). 668–671. 32 indexed citations
20.
Karbwang, Juntra & K Na‐Bangchang. (1994). Clinical application of mefloquine pharmacokinetics in the treatment of P falciparum malaria. Fundamental and Clinical Pharmacology. 8(6). 491–502. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026